Lenalidomide for the treatment of multiple myeloma in people who have received at least one prior therapy
This is an extract from the guidance and may be misleading if read alone. The complete guidance is available at guidance.nice.org.uk/ta171
Important information about this guidance
Following the BBC documentary The Price of Life broadcast on 17 June, NICE has published guidance on the use of lenalidomide for multiple myeloma on its website ahead of the scheduled publication date. The guidance will be formally issued to the NHS when we launch other guidance on 24 June 2009. Accordingly, the Secretary of State's direction requiring NHS organisations to make funding available for NICE recommended treatments within 3 months of final guidance being published will begin ON 24 June.
This guidance was developed using the NICE single technology appraisals process: www.nice.org.uk/aboutnice/howwework/devnicetech/developing_nice_technology_appraisals.jsp